UK markets open in 4 hours 59 minutes

MorphoSys AG (MOR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.01+0.01 (+0.20%)
At close: 03:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 726.98M
Enterprise value 292.12M
Trailing P/E N/A
Forward P/E 322.58
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.60
Price/book (mrq)N/A
Enterprise value/revenue 1.17
Enterprise value/EBITDA -0.57

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 3-35.27%
S&P500 52-week change 3-9.08%
52-week high 37.99
52-week low 33.17
50-day moving average 34.17
200-day moving average 34.88

Share statistics

Avg vol (3-month) 3185.53k
Avg vol (10-day) 362.45k
Shares outstanding 5136.64M
Implied shares outstanding 6N/A
Float 8102.9M
% held by insiders 10.00%
% held by institutions 16.07%
Shares short (12 Jan 2023) 4148.73k
Short ratio (12 Jan 2023) 40.5
Short % of float (12 Jan 2023) 4N/A
Short % of shares outstanding (12 Jan 2023) 40.11%
Shares short (prior month 14 Dec 2022) 454.02k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-89.66%

Management effectiveness

Return on assets (ttm)-4.88%
Return on equity (ttm)-337.12%

Income statement

Revenue (ttm)249.61M
Revenue per share (ttm)1.83
Quarterly revenue growth (yoy)132.20%
Gross profit (ttm)147.42M
EBITDA -217.01M
Net income avi to common (ttm)-861.48M
Diluted EPS (ttm)-4.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.04B
Total cash per share (mrq)7.64
Total debt (mrq)334.61M
Total debt/equity (mrq)N/A
Current ratio (mrq)3.76
Book value per share (mrq)-0.63

Cash flow statement

Operating cash flow (ttm)-417.2M
Levered free cash flow (ttm)-167.55M